NEW PATHWAYS TO SMARTER MEDICINETM

Bringing hope to millions of patients by creating new medicines that treat serious medical needs. More

Optimizing therapeutic benefit with our unparalleled expertise in polymer chemistry. More

Advancing the treatment of autoimmune disorders, chronic inflammatory conditions and cancer with novel therapies which selectively modulate the immune system. More

Discover Our approach

Restoring the immune system balance with T regulatory cells – Interview with Dr Christie Fanton

WATCH

Explore the role of the interleukin-15 (IL-15) pathway in immune response.

WATCH

Events

  • Aug 08

    Q2 2024 Financial Results

    Virtual

    5:00 PM, EDT

    Listen to Webcast

  • Apr 04

    Evercore ISI Diamonds in the Rough Webinar

    Virtual

    11:30 AM EDT

    Listen to Webcast

  • Nov 07

    Q3 2023 Financial Results

    Virtual

    5:00 PM EDT

    Listen to Webcast

  • Aug 08

    Q2 2023 Financial Results

    Virtual

    2:00 PM, PT

    Listen to Webcast

  • Jun 14

    Goldman Sachs 44th Annual Global Healthcare Conference

    Dana Point, CA

    1:20 PM, PT

    Listen to Webcast

Latest News

Content placeholder

    OUR PIPELINE

    We are focused on creating novel therapies aimed at selectively modulating the immune system to advance the treatment of autoimmune disorders, chronic inflammatory conditions and cancer.

    AUTOIMMUNE DISORDERS

    REZPEG

    IMMUNOLOGY

    PEG-CSF1

    IMMUNOLOGY

    TNFR-2

    • 9

      Million patients benefit from our medicines

    • 12

      Approved products around the world

    • 6

      R&D Pipeline Programs

    Join Nektar Team

    Join Our Team

    Find out what it’s like to be part of a dynamic team full of diverse perspectives and unique ideas, brought together by expertise and a passion for making a difference for patients with unmet medical needs.

    Read More